tiprankstipranks
Trending News
More News >
VSee Health (VSEE)
NASDAQ:VSEE
US Market

VSee Health (VSEE) AI Stock Analysis

Compare
130 Followers

Top Page

VS

VSee Health

(NASDAQ:VSEE)

46Neutral
VSee Health's strong revenue growth and recent strategic contracts position it well in a growing industry. However, the company's financial instability, marked by negative profitability and cash flow, presents significant risks. Positive technical indicators and strategic corporate events support the stock, but the negative valuation metrics remain a concern.

VSee Health (VSEE) vs. S&P 500 (SPY)

VSee Health Business Overview & Revenue Model

Company DescriptionVSee Health (VSEE) is a telemedicine and telehealth technology company that specializes in providing secure, HIPAA-compliant video conferencing solutions for healthcare providers. The company focuses on enhancing patient engagement and streamlining healthcare delivery through its range of telehealth software and services. VSee Health's offerings include virtual patient visit platforms, remote patient monitoring, and digital health integration tools designed to improve access to care and facilitate seamless communication between healthcare providers and patients.
How the Company Makes MoneyVSee Health makes money through a subscription-based revenue model where healthcare providers, hospitals, and clinics pay for access to its telehealth solutions. Key revenue streams include licensing fees for its software platforms, customization services for healthcare systems, and ongoing technical support and maintenance fees. The company may also generate revenue from partnerships with electronic health record (EHR) systems and other healthcare technology firms to integrate its solutions into broader healthcare IT ecosystems. Factors such as the increasing demand for remote healthcare services and the growing adoption of telemedicine technologies contribute significantly to VSee Health's earnings.

VSee Health Financial Statement Overview

Summary
VSee Health is experiencing robust revenue growth, but the lack of profitability and negative cash flow metrics indicate financial instability. High liabilities and negative equity in prior periods suggest financial risk, necessitating significant improvements in operational efficiency and financial management.
Income Statement
30
Negative
The company shows significant revenue growth in the TTM period, with a 38% increase compared to the previous year. However, it struggles with negative profitability metrics, such as a negative EBIT and net income, reflecting ongoing challenges in achieving operational efficiency.
Balance Sheet
20
Very Negative
The balance sheet reveals a concerning financial stability, with high total liabilities compared to stockholders' equity. The debt-to-equity ratio is unfavorable, indicating a high reliance on debt financing, and the negative equity in previous periods raises red flags about financial health.
Cash Flow
25
Negative
The cash flow statement highlights negative operating and free cash flows, pointing to liquidity issues. Despite positive investing cash flow, the company's operational cash flows are insufficient to cover its expenses, indicating potential cash management issues.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
8.06M5.84M6.38M7.34M6.80M
Gross Profit
5.85M3.91M4.84M5.92M5.46M
EBIT
-58.87M-1.47M-3.59M-282.67K404.50K
EBITDA
-55.26M-2.24M-1.59M-282.67K-45.03K
Net Income Common Stockholders
-55.91M-3.45M-3.24M-280.70K258.88K
Balance SheetCash, Cash Equivalents and Short-Term Investments
230.66K118.73K107.00K760.01K775.24K
Total Assets
2.61M830.79K7.63M117.94M2.73M
Total Debt
517.13K543.00K642.80K0.00133.08K
Net Debt
286.47K424.27K535.80K-760.01K-642.16K
Total Liabilities
2.61M4.24M7.67M4.55M2.11M
Stockholders Equity
360.72K-3.09M-31.25K113.39M614.49K
Cash FlowFree Cash Flow
-2.27M-636.93K-1.45M-600.11K789.12K
Operating Cash Flow
-2.21M-632.60K-1.45M-600.11K789.12K
Investing Cash Flow
6.78M6.52M110.12M-116.73M0.00
Financing Cash Flow
-1.45M-5.66M-109.32M118.09M-83.67K

VSee Health Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.05
Price Trends
50DMA
1.41
Negative
100DMA
1.46
Negative
200DMA
2.14
Negative
Market Momentum
MACD
-0.08
Negative
RSI
43.11
Neutral
STOCH
23.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VSEE, the sentiment is Negative. The current price of 1.05 is below the 20-day moving average (MA) of 1.18, below the 50-day MA of 1.41, and below the 200-day MA of 2.14, indicating a bearish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 43.11 is Neutral, neither overbought nor oversold. The STOCH value of 23.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VSEE.

VSee Health Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$9.68B52.7621.24%17.47%49.87%
71
Outperform
$5.96B50.9230.71%69.33%
67
Neutral
$1.66B103.762.21%5.61%
64
Neutral
$13.37B9.309.39%4.85%16.11%-8.85%
46
Neutral
$17.07M-3190.66%-806.84%
45
Neutral
$1.27B-52.46%-1.26%-338.56%
43
Neutral
$110.21M-54.13%-1.81%70.88%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VSEE
VSee Health
1.05
-10.95
-91.25%
TDOC
Teladoc
7.25
-6.30
-46.49%
HIMS
Hims & Hers Health
27.23
14.01
105.98%
AMWL
American Well
7.06
-4.09
-36.68%
GDRX
GoodRx Holdings
4.42
-2.13
-32.52%
DOCS
Doximity
52.85
27.43
107.91%

VSee Health Corporate Events

Business Operations and Strategy
VSee Health Secures Major Contract Renewal in Telehealth
Positive
Jan 30, 2025

On January 27, 2025, VSee Health announced a contract renewal worth approximately $870,000 with a nationwide mental and behavioral healthcare provider. This renewal highlights VSee’s strong client retention and the value of its platform in delivering high-quality mental healthcare solutions. As the digital mental health market is expected to grow significantly, VSee is well-positioned to capitalize on this opportunity with its innovative telehealth technology.

Business Operations and Strategy
VSee Health Secures $935K in Medtech Contracts
Positive
Jan 27, 2025

On January 21, 2025, VSee Health announced contracts worth approximately $935,000 with several medical technology solution companies. These contracts highlight VSee’s role in addressing critical challenges in the medtech industry by providing remote support and operational capabilities that enhance customer ROI. VSee is positioned to capitalize on the medtech industry’s growth, utilizing its scalable platform to improve customer experiences and drive adoption of advanced medical technologies.

Business Operations and Strategy
VSee Health Secures Major Contracts in Telehealth Expansion
Positive
Jan 16, 2025

On January 10, 2025, VSee Health announced a notable contract with a leading health system in Florida valued at $160,000, with potential for further growth if deployment expands. This agreement emphasizes the company’s dedication to healthcare innovation through its advanced telehealth solutions. Additionally, on January 13, 2025, VSee Health reported securing a multi-year government contract with $6 million allocated for the first year, reinforcing its growing influence in the digital health sector and positioning it to meet the increasing demand for telehealth solutions, thereby enhancing patient care and delivering long-term value for stakeholders.

Product-Related AnnouncementsBusiness Operations and Strategy
VSee Health Expands Telehealth Reach with New Agreements
Positive
Dec 23, 2024

VSee Health has secured a national group purchasing agreement for teleradiology services with Premier, Inc., and a teleradiology contract with a major U.S. post-acute care hospital system, highlighting its strategic positioning in the telehealth industry. These agreements enable VSee to expand access to its telehealth solutions amid growing demand for remote imaging services, aligning with industry trends and enhancing its market presence in the expanding global radiology sector.

Product-Related AnnouncementsBusiness Operations and Strategy
VSee Health Partners with Tele911 for Virtual ER
Positive
Dec 18, 2024

VSee Health announced a partnership with Tele911 to create the first virtual emergency department, combining telehealth innovation with emergency care solutions to address ER overcrowding and EMS staffing challenges. This collaboration aims to extend Tele911’s reach, targeting over 10 million lives by the end of 2025, and involves onboarding over 300 new fire and EMS agencies, addressing systemic challenges in emergency healthcare while providing scalable, secure solutions to ensure emergency care availability.

Product-Related AnnouncementsBusiness Operations and Strategy
VSee Health Partners with AbundaBox for Health Platform
Positive
Dec 11, 2024

VSee Health has announced a strategic partnership with AbundaBox to introduce AbundaLife™, an innovative health record management platform designed to consolidate personal health data, streamline healthcare management, and improve health outcomes by providing unified access to medical records. The collaboration aims to address inefficiencies in healthcare management and enhance the patient experience, with eight healthcare facilities already adopting the platform in its initial rollout, indicating potential for significant market adoption and revenue growth.

Product-Related AnnouncementsBusiness Operations and Strategy
VSee Health Launches Virtual Oral Health Service
Positive
Nov 25, 2024

VSee Health and The TeleDentists have joined forces to launch the first virtual oral health compliance service on the PointClickCare Marketplace, aimed at revolutionizing senior care. This partnership offers telehealth solutions to improve oral health for seniors in long-term care facilities, addressing CMS regulations and enhancing care accessibility. By reducing the need for physical dentist visits, this integration promises better health outcomes, lower costs, and increased efficiency, especially for seniors with mobility challenges.

Business Operations and Strategy
VSee Health Expands Telehealth Pilot in Cameroon
Positive
Nov 20, 2024

VSee Health, Health Tech Without Borders, and iDocta are expanding their Project VITAL Africa telehealth pilots to improve healthcare access in Cameroon. This initiative aims to provide sustainable training and innovative telehealth solutions in conflict-affected regions, addressing significant challenges such as high maternal mortality rates and inadequate healthcare access. By collaborating with local and international partners, the project emphasizes sustainability and equity, aiming to empower communities facing humanitarian and climate-related crises.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.